CLOSE
WEBSITE OF THE STATE OF SOUTH DAKOTA DEPARTMENT OF HEALTH
Melissa Magstadt, South Dakota Secretary of Health

South Dakota Department of Health Logo and covid.sd.gov button.

COVID-19 Vaccine Information

for healthcare providers

NOTE: Please check this web page twice weekly for updated material.

Provider Enrollment Instructions

Vaccinator TrainingStorage & Handling TrainingVaccine Data Entry Training Vaccine Coordinator Training

VIEW HEALTHCARE PROVIDER WEBINARS & SLIDES FOR UPDATES, CHARTS, HIGHLIGHTS, ETC.

Updates for Vaccine Providers

UPDATED CDC GUidance for Covid-19 vaccination

  • New recommendation for children ages 6 months–4 years who complete a Moderna primary series to receive 1 bivalent Moderna booster dose at least 2 months after completion of the primary series.

  • Children age 5 years who complete a Moderna primary series may receive either the previously authorized bivalent Pfizer-BioNTech booster dose or the newly authorized bivalent Moderna booster dose at least 2 months after completion of the Moderna primary series.

  • The previously authorized 3-dose Pfizer-BioNTech primary series for children ages 6 months–4 years has been revised as follows: a monovalent Pfizer-BioNTech vaccine is administered for the first and second doses, followed by 1 bivalent Pfizer-BioNTech vaccine as the third primary series dose, at least 8 weeks after the second monovalent primary series dose. A booster dose is not authorized for children in this age group who receive a Pfizer-BioNTech 3-dose primary series, including children who previously received a 3-dose monovalent Pfizer-BioNTech primary series.

To view all updates, please visit CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States.

List of Expiry Look-up Pages  

You may also refer to the CDC Operational Guidance on Identification, Reporting and Disposal of COVID-19 Vaccine.

Resources, educational opportunities

Adult Ancillary Kit Opt-out

  • J&J opt-out is available

  • Moderna opt-out is available

  • Pfizer ADULT opt-out is now available

If you wish to not receive ancillary kits, please indicate this in the notes section of the order screen in SDIIS.


Updated information:

Pfizer-BioNTech COVID-19 Vaccine

Pfizer-BioNTech Resources:

Vaccine Inventory Reminders

Cartons and vials of Pfizer-BioNTech COVID-19 PURPLE Cap vaccine with labeled expiration dates of October 2021 through November 2022 may now be used beyond the printed date. The new updated expiry dates can be found HERE. These vaccines may remain in use until the updated expiration date providing approved storage conditions have been maintained.

We appreciate your efforts to reduce the Pfizer PURPLE Cap vaccine inventory in the field, which continues to decline. Please continue to use Pfizer PURPLE Cap before ordering the Pfizer Tris GRAY Cap. Remember to keep your inventory of the purple and gray cap vials separate to avoid any confusion. Purple cap vials require diluent while gray cap vials do not.

PFIZER WEBINARS FOR HEALTHCARE PROVIDERS
COVID-19 Vaccine Medical Updates and Immunization Site Training

Contact Information: https://www.pfizer.com/contact

Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine Janssen COVID-19 Vaccine

Janssen Website

Shelf Life Extension for the Johnson & Johnson's Janssen COVID-19 Vaccine

The Food & Drug Administration announced the approval of a shelf life extension for the Johnson & Johnson's Janssen COVID-19 vaccine for an additional three months. The shelf life of this vaccine has been updated from 6 months to 9 months. This decision is based on data from ongoing stability assessment studies, which have demonstrated that the vaccine is stable at 9 months when refrigerated at temperatures of 36° – 46° Fahrenheit (2°– 8° Celsius).

This shelf life extension applies to all inventory dated to expire on March 7, 2022 or later. Vaccine dated prior to March 7, 2022 should be disposed of according to state and local regulation and reported as waste according to your COVID-19 provider agreement. Vaccine providers should visit the Janssen COVID-19 Vaccine Expiry Checker webpage to confirm the expiration dates. This shelf life extension applies to refrigerated vials of J&J/Janssen COVID-19 vaccine that have been held in accordance with the manufacturer's storage conditions.

COVID-19 vaccines that are authorized under an EUA do not have fixed expiration dates, and expiration dates may be extended as we get more stability data. Always check the manufacturer's website to obtain the most up-to-date expiration dates for the COVID-19 vaccines you have on hand.

Janssen Resources:

Contact Information:

VaccineFinder (VF)

As of May 1, 2022, providers must report COVID-19 vaccine supply levels at least WEEKLY by close of business on Fridays. All other provisions regarding data remain unchanged.

Resources:

  • Provider Resources

    • Guides on account creation, inventory reporting, and setting your location to display to the public.

  • Vaccines.gov Reporting

    • Additional information for providers, including check lists for public display on vaccinefinder.org

Contact Information:

VAERS - Vaccine Adverse Event Reporting System

VAERS Website - Healthcare providers are required by law to report to VAERS

Contact VAERS at:

  • Phone: 800-822-7967 | Fax: 877-721-0366 | E-mail: info@vaers.org   

  • For non-urgent concerns, email covid19vaxsafety@cdc.gov. For emergencies relating to COVID-19 vaccine safety, call CDC Emergency Operations Center at (770) 488-7100.

 
V-Safe

v-safe website - CDC is requesting that healthcare providers give patients a v-safe information sheet at the time of vaccination and encourage them to enroll and fill out the surveys when prompted to do so.

Contact Information: Call 800-232-4636 | TTY 888-232-6348 | Open 24 hours, 7 days a week

General Vaccine Guidance and Resources

Pregnancy & Breastfeeding Vaccination Guidance

Pediatric Vaccination Guidance

Vaccination Clinic Guidance

Long-Term Care Facility Guidance

Storage and Handling Guidance

Post-Vaccination Guidance

Fact Sheets & Communication Resources

South Dakota Vaccination Plan

Share via: